healthcare.digital January 9, 2026
The Macro Strategic Landscape of 2026: From Venture Subsidies to Industrial Logic
The European healthcare technology and medical technology (MedTech) landscape entering 2026 stands at a profound inflection point, characterised by a transition from the speculative fragmentation of the early 2020s to a disciplined era of “industrial maturity”. Following a period of post-pandemic recalibration in 2024 and a tentative recovery in 2025, the market is poised for a robust, albeit structurally transformed, resurgence in capital deployment and mergers and acquisitions (M&A).
The defining thesis for venture capital (VC) and private equity (PE) in 2026 is “Industrialisation”. This concept signifies a departure from the “growth at all costs” paradigm that defined the Zero Interest Rate Policy (ZIRP) era. In that previous...
Today's Sponsors
Today's Sponsor